We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

49 hedge funds and large institutions have $623M invested in Editas Medicine in 2016 Q1 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
1.31%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.11%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$142M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$56.1M
3
DM
Deerfield Management
New York
+$44.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$37.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$19.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$187M +$142M +5,402,030 New
PVMCV
2
Polaris Venture Management Co VI
Massachusetts
$161M +$122M +4,656,173 New
Viking Global Investors
3
Viking Global Investors
Connecticut
$73.8M +$56.1M +2,135,523 New
DM
4
Deerfield Management
New York
$59M +$44.9M +1,709,400 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$47.2M +$37.1M +1,409,896 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$25.9M +$19.7M +750,292 New
Capital World Investors
7
Capital World Investors
California
$10.2M +$7.75M +295,000 New
AI
8
Alphabet Inc
California
$8.86M +$6.74M +256,410 New
WCM
9
Wildcat Capital Management
New York
$8.56M +$6.51M +247,768 New
Jennison Associates
10
Jennison Associates
New York
$5.7M +$4.49M +170,940 New
BFA
11
BlackRock Fund Advisors
California
$5.49M +$4.18M +158,919 New
Morgan Stanley
12
Morgan Stanley
New York
$4.93M +$3.75M +142,754 New
OFM
13
Omega Fund Management
Massachusetts
$3.63M +$2.76M +105,007 New
EC
14
EcoR1 Capital
California
$3.04M +$2.31M +87,921 New
CC
15
Casdin Capital
New York
$2.95M +$2.25M +85,470 New
JP Morgan Chase
16
JP Morgan Chase
New York
$2.5M +$1.91M +72,500 New
Goldman Sachs
17
Goldman Sachs
New York
$2.4M +$1.83M +69,641 New
BIT
18
BlackRock Institutional Trust
California
$1.99M +$1.52M +57,666 New
State Street
19
State Street
Massachusetts
$1.19M +$907K +34,511 New
SG Americas Securities
20
SG Americas Securities
New York
$1.16M +$880K +33,484 New
BIM
21
BlackRock Investment Management
Delaware
$877K +$667K +25,381 New
Barclays
22
Barclays
United Kingdom
$824K +$637K +24,240 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$595K +$453K +17,225 New
Northern Trust
24
Northern Trust
Illinois
$518K +$394K +14,999 New
TCIM
25
TIAA CREF Investment Management
New York
$518K +$394K +15,007 New
1
2

EDIT Hedge Fund Activity: Q1 2016 in Review

49 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2016, worth a combined $623M.

Buyers outnumbered sellers: 49 funds opened new EDIT positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $142M.

  • 49 institutional investors held Editas Medicine (EDIT) as of Q1 2016, up from 0 in Q4 2015.
  • Funds reported $623M of Editas Medicine stock for Q1 2016.
  • 49 funds opened new Editas Medicine positions in Q1 2016 and 0 closed out, a net change of +49 holders.
  • The largest Editas Medicine buyer in Q1 2016 was Fidelity Investments, an estimated $142M added.

Based on aggregated 13F filings for Q1 2016.